Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Income from Continuing Operations: 2018-2025

Historic Income from Continuing Operations for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Sep 2025 value amounting to -$13.4 million.

  • Arcturus Therapeutics Holdings' Income from Continuing Operations fell 94.81% to -$13.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$66.7 million, marking a year-over-year decrease of 6.57%. This contributed to the annual value of -$80.9 million for FY2024, which is 172.30% down from last year.
  • Per Arcturus Therapeutics Holdings' latest filing, its Income from Continuing Operations stood at -$13.4 million for Q3 2025, which was down 46.49% from -$9.2 million recorded in Q2 2025.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Income from Continuing Operations peaked at $118.6 million during Q4 2022, and registered a low of -$57.7 million during Q1 2021.
  • Over the past 3 years, Arcturus Therapeutics Holdings' median Income from Continuing Operations value was -$14.1 million (recorded in 2025), while the average stood at -$13.4 million.
  • Per our database at Business Quant, Arcturus Therapeutics Holdings' Income from Continuing Operations slumped by 509.45% in 2021 and then skyrocketed by 415.16% in 2022.
  • Arcturus Therapeutics Holdings' Income from Continuing Operations (Quarterly) stood at -$37.6 million in 2021, then soared by 415.16% to $118.6 million in 2022, then plummeted by 109.84% to -$11.7 million in 2023, then slumped by 156.89% to -$30.0 million in 2024, then slumped by 94.81% to -$13.4 million in 2025.
  • Its Income from Continuing Operations was -$13.4 million in Q3 2025, compared to -$9.2 million in Q2 2025 and -$14.1 million in Q1 2025.